Roche New Zealand operates across two businesses, Pharmaceuticals and Diagnostics. Our aim is to enable New Zealanders access to our medicines and diagnostic tests to detect illnesses early, and to treat them with life-saving and life-changing medicines.
New Zealanders currently have access to 27 Roche medicines, 16 of which are funded. New Zealand also plays an important role in Roche’s global research and development network. In fact, Roche is the largest investor in clinical trials in Aotearoa having invested more than $30 million over the last 5 years.
We have one purpose: to do now what patients need next.
New Zealanders currently have access to 27 Roche medicines, 16 of which are funded. New Zealand also plays an important role in Roche’s global research and development network. In fact, Roche is the largest investor in clinical trials in Aotearoa having invested more than $30 million over the last 5 years.
We have one purpose: to do now what patients need next.
